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Abstract. Desmogleins are members of the cadherin 
superfamily which form the core of desmosomes. In 
vitro studies indicate that the cytoplasmic domain of 
desmogleins associates with plakoglobin; however, lit- 
tle is known about the role of this domain in desmo- 
some recognition or assembly in vivo, or about the pos- 
sible relation of desmoglein mutations to epidermal 
differentiation and disease. To address these questions 
we used transgenic mouse technology to produce an 
NH2-terminally truncated desmoglein (Pemphigus Vul- 
garis Antigen or Dsg3) in cells known to express its 
wild-type counterpart. Within 2 d, newborn transgenic 
animals displayed swelling of their paws, flakiness on 
their back, and blackening of the tail tip. When ana- 
lyzed histologically and ultrastructurally, widening of 
intercellular spaces and disruption of desmosomes were 
especially striking in the paws and tail. Desmosomes 
were reduced dramatically in number and were smaller 
and often peculiar in structure. Immunofluorescence 
and immunoelectron microscopy revealed no major ab- 
normalities in localization of hemidesmosomal compo- 
nents, but desmosomal components organized aber- 
rantly, resulting in a loss of ultrastructure within the 
plaque. In regions where desmosome loss was prevalent 
but where some adhesive structures persisted, the epi- 
dermis was thickened, with a marked increase in 
spinous and stratum corneum layers, variability in gran- 
ular layer thickness, and parakeratosis in some regions. 
Intriguingly, a dramatic increase in cell proliferation 
was also observed concomitant with biochemical 
changes, including alterations in integrin expression, 
known to be associated with hyperproliferation. An in- 
flammatory response was also detected in some skin re- 
gions. Collectively, these findings demonstrate that a 
mutation in a desmoglein can perturb epidermal cell- 
cell adhesion, triggering a cascade of changes in the 
skin. 
PIDERMAL cells have two major types of homophilic, 
cell-cell  adhesion junctions:  one  is  mediated by 
classical cadherins, primarily E-cadherin, and the 
other is mediated by desmosomal cadherins, including des- 
mocollins and desmogleins (Hynes, 1992; Garrod,  1993; 
Schmidt et al., 1994). Whereas reductions in E-cadherins 
have been associated with various forms of epithelial can- 
cers (Takeichi, 1993; Birchmeier and Behrens, 1994), au- 
toantibodies to the extracellular portions of desmogleins 1 
and 3, respectively, have been associated with the patho- 
genesis of the  autoimmune disorders,  Pemphigus Folia- 
ceus, and Pemphigus Vulgaris (Stanley, 1993).  It has not 
yet been established whether mutations in desmogleins 1 
or 3 can elicit some or all of the pathological features asso- 
ciated with these disorders, including disruption of desmo- 
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somes, acantholysis, and in some cases, eosinophilic ab- 
scesses. 
All cadherins have tripartate functional domains: (1)  a 
calcium-inducible,  extracellular  amino-terminal  domain, 
important for homophilic intercellular associations; (2)  a 
single transmembrane-spanning domain; and (3)  a  cyto- 
plasmic domain that anchors the cytoskeleton, an essential 
process for cell adhesion (Nagafuchi and Takeichi, 1988; 
Ozawa and Kemler, 1992).  Whereas the cytoplasmic do- 
main of E-cadherin links to the actin cytoskeleton, the cy- 
toplasmic domains of desmosomal cadherins link to the in- 
termediate filament cytoskeleton. 
Desmocollins and desmogleins are coexpressed and of- 
ten colocalized in all cells where desmosomes are found. 
The relative roles of these two cadherins in intercellular 
adhesion have only recently begun to be addressed. In ele- 
gant experiments by Troyanovsky et al. (1993),  epithelial 
cancer  cells  expressing  a  recombinant connexin-desmo- 
collin I produced a unique membrane-associated complex 
consisting of desmoplakin, plakoglobin, the chimeric pro- 
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analogous  chimeric protein, composed  of connexin and 
the cytoplasmic domain of desmoglein I, integrated into 
and disrupted endogenous desmosomes in cultured cells. 
Collectively, these studies suggest that the cytoplasmic tail 
of desmoglein I possesses information that can direct it to 
desmosomes, although it may not necessarily be essential 
in establishing the membrane-cytoskeletal connection. 
Immunoprecipitation and  gel  overlay assays  with  cul- 
tured cell extracts or recombinant proteins indicate that at 
least one desmosomal component, plakoglobin, can inter- 
act directly with a specific segment of the desmoglein tail 
(Troyanovsky et al.,  1993, 1994; Mathur et al.,  1994; Roh 
and Stanley, 1995). Whether the association between des- 
moglein and plakoglobin exists within the actual desmo- 
somes seems likely, but remains unknown. It is  also not 
clear whether desmogleins are required to build a structur- 
ally functional and stable desmosome. 
In  the  present  study,  we  focus on the  in  vivo conse- 
quences of expressing an amino-terminally truncated form 
of a human desmoglein in the epidermis of mice. We pat- 
terned our mutation after an N-cadherin mutant, shown to 
disrupt cadherin-mediated adherens junctions in vitro and 
in vivo (Kintner, 1992; Fujimori and Takeichi, 1993; Le- 
vine et al., 1994; Hermiston and Gordon, 1995), and used 
the keratin 14 promoter to drive expression of our trans- 
gene. While this promoter is known to target gene expres- 
sion to the basal layer of transgenic mouse epidermis, sta- 
ble transgene products expressed by this promoter often 
persist in the lower spinous layers (Vassar et al., 1989). 
Of the three epidermal desmogleins, Dsg2 is globally ex- 
pressed in nonepidermal tissues and Dsgl is restricted to 
the uppermost layers of the epidermis; only Dsg3 is known 
to be expressed in the basal and lower spinous layers of 
the epidermis and other tissues in which K14 is expressed 
(Arnemann et al., 1993; see also Stanley, 1993; Schmidt et 
al.,  1994).  We focused on Dsg3, not only because its ex- 
pression pattern is most likely to mimic that of the trans- 
gene, but also because it is the Pemphigus Vulgaris Anti- 
gen  (PVA) 1,  and  patients  with  this  severe  blistering 
autoimmune disease produce antibodies against this pro- 
tein  (Amagai  et  al.,  1991;  Stanley,  1993).  Therefore, a 
Dsg3 study was likely to have significant clinical, as well as 
biological implications. 
We show that a truncated Dsg3, Dsg3AN, elicits pertur- 
bations in desmosomes, accompanied by gross changes in 
the organization and differentiation of epidermal cells. In 
addition, a marked increase in cell proliferation is elicited 
in areas where cell adhesion is not completely lost. In re- 
gions where adhesion is lost entirely, there are pyknotic 
nuclei  and  signs  of  keratinocyte  degeneration.  Finally, 
marked edema and an inflammatory response is  seen in 
the paw skin of transgenic neonatal mice. We discuss the 
significance of these and additional findings in relation to 
Pemphigus Vulgaris and other epidermal diseases, and in 
relation to possible functions for Dsg3  and the  proteins 
with which Dsg3 associates. 
1. Abbreviations used in this paper. BrdU, bromodeoxyuridine; NGS, nor- 
mal goat serum; PPK, palmoplantar keratoderma; PVA, Pemphigus Vul- 
gaffs Antigen. 
Materials and Methods 
Construction of the Expression Vector and Generation 
of Transgenic Mice 
Human  Dsg3  (PVA) cDNAs were cloned from a  human epidermis 5' 
stretch eDNA library (Clontech, Palo Alto, CA) by using primers derived 
from the published sequence (Amagai et al., 1991). The full-length eDNA 
was assembled from three overlapping clones and from a small PCR prod- 
uct encompassing nucleotides 65-289. 
To remove nucleotides 295-1790,  encoding amino acid residues 72-569, 
a PCR mutagenesis strategy was used. A chimeric primer was made that 
contained nucleotides 276-294 of the Dsg3 coding sequence, directly fol- 
lowed by nucleotides 1791-1809.  Using PFU polymerase, a PCR product 
was generated using this and a second 5' primer encompassing nucleotides 
65-87, resulting in a  "loop-out" deletion of the desired sequences. The 
PCR product was purified and used as a primer in another round of ampli- 
fication, this time with a  second PCR primer encompassing nucleotides 
1959-1979.  This product was ligated to the 3' sequence of Dsg3, and fi- 
nally, the Flag epitope tag was inserted at nucleotide 288, downstream of 
the signal peptide and the propeptide processing sequences of the mature 
protein. Sequencing was used to verify the identity and fidelity of the 
Dsg3 sequence and the cloning steps. The truncated Dsg3, referred to as 
Dsg3AN, was then subcloned into the KI4 expression vector and intro- 
duced into the germline of CD-1 mice as described previously (Vassar et 
al., 1989). 
Immunofluorescence and Immunohistochemistry 
Frozen sections of tissues were subjected to double indirect immunofluo- 
rescence. Sections of paraffin-embedded tissues were preblocked with 
20% normal goat serum (NGS) and subjected to immunogold histochem- 
istry using primary antibodies in 1% NGS (see Vassar et al., 1989). The 
following primary antibodies were used: rabbit anti-plakoglobin (a gift 
from Dr. Jacqueline Papkoff, Sugen Inc., Redwood City, CA); rabbit anti- 
K6 (a gift from Dr. Dennis Roop, Baylor University, Houston, TX); rabbit 
anti-filaggrin (a gift from Dr. Beverly Dale, University of Washington, Se- 
attle, WA); rabbit anti-desmocollin (a gift from Dr. David Garrod, Uni- 
versity of Manchester, England); mouse anti-Flag (M2; IBI Corp., New 
Haven, CT); mouse anti-desmoglein (DG3.1;  American Research Prod- 
ucts, Belmont, MA); rat anti-E cadherin (Zymed Laboratories, San Fran- 
cisco, CA); rat anti-131 integrin (Pharmagen, San Diego, CA); rabbit anti- 
K14 (Vassar et al., 1989); rabbit anti-loricffn (Fuchs, E., K. Turksen, and 
L. Milstone, unpublished data); rabbit anti-desmoplakin (Kouklis et al., 
1994). HRP- and fluorescence-conjugated secondary antibodies were ob- 
tained from Jackson ImmunoResearch Laboratories (West Grove, PA), 
and auro probe goat anti-rabbit antiserum was obtained from Amersham 
Life Sciences (Arlington Heights, IL). 
Ultrastructural Analysis 
For regular EM, tissues were fixed in 2.5% glutaraldehyde in 0.1 M phos- 
phate buffer and postfixed in 1.5 % osmium tetroxide. The specimens were 
processed and stained on grids with uranyl acetate and lead citrate and ex- 
amined with an electron microscope (100 CX; JOEL, USA, Inc., Peabody, 
MA) at 80 kv. For immunoEM, tissues were embedded in Lowicryl 4M as 
described previously (Coulombe et al., 1991). Rabbit polyclonal antisera 
used were:  anti-plakoglobin, anti-desmoplakin, and  anti-E-cadherin (a 
gift from Dr. W. James Nelson, Stanford University, Palo Alto, CA). 
Results 
Generation of the Transgene and Production of Mice 
Expressing Dsg3AN 
As discussed above, an NH2-terminally truncated form of 
a desmoglein was a  good candidate for (a) assessing the 
consequences of disrupting desmosomes in vivo, and (b) 
assessing the potential relevance of desmoglein mutations 
to human disease. Therefore, we engineered the transgene 
construct shown in Fig.  1 A.  We preserved the peptide 
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(A) Dsg3AN transgene construct. The vector is pBluescript  KS+. 
The components of this plasmid are the 5' upstream sequence  of 
the human K14 gene (Vassar et al.,  1989) extending  from the 
translation  initiation  codon  and 5' untranslated  sequence  to  a 
HindlII site  located  ,'-~2.1 kb  5'  to  the  TATA box,  a  rabbit 
13-globin intron, sequences encoding the leader peptide of human 
Dsg3  and  additional  amino-terminal sequence  (black  stippled 
boxes),  sequences  encoding  the  FLAG  epitope tag  (flag),  se- 
quences encoding the transmembrane domain (black box), entire 
cytoplasmic tail of human Dsg3 (black dotted box), and the K14 
polyadenylation sequence (white box). (B-D) Phenotype of 5-6-d- 
old mice expressing Dsg3AN. Note the flakiness of their skin (up- 
per arrow in D  and arrows  in B) and also the blackened tail of 
each transgenic mouse. The tails developed blackening by ~2 d of 
age (arrow in C, compare with control littermate's tail on the left), 
and tails became progressively shorter until as adults, they were 
only stubs. Note also the swellings of the paws, a consistent  fea- 
ture of 2-7-d-old transgenic mice (D; lower arrow and bracket). 
leader and processing sequence for proper surface assem- 
bly of the molecule, and we added an epitope FLAG se- 
quence just after the processing sequence so that we could 
monitor expression  and  localization of the  protein.  This 
left a  small segment of the extracellular domain and  the 
entire  transmembrane and cytoplasmic domains of Dsg3 
intact.  As judged  by immunofluorescence  of transfected 
cultured cells, the transgene product had the ability to lo- 
calize to the  plasma membrane (data not shown).  Addi- 
tional data supportive of this notion are provided below. 
Mice expressing Dsg3AN were produced using an out- 
bred strain (CD-1) as described previously (Vassar et al., 
1989). Seven mice were transgenic as judged by PCR anal- 
ysis of their skin DNAs. Of these, two independently de- 
rived transgenic animals were bred separately to generate 
two lines of F1 offspring. One of the founder animals was 
mosaic, and gave rise to a mixture of positive and negative 
offspring. All F1  offspring that carried the transgene dis- 
played  phenotypic  abnormalities  that  were  inheritable. 
Since the two lines exhibited similar phenotypes, the aber- 
rations  were  attributed  to  transgene  expression  rather 
than  transgene  integration  sites.  Collectively, these  data 
indicated that expression of Dsg3AN had deleterious con- 
sequences for the animals. 
There  were  three  peculiarities  characteristic  of all  af- 
fected, neonatal  F1  transgenic  mice (Fig.  1,  B-D).  First, 
within 2 d after birth, the animals developed swollen paws 
and digits. Second, the animals often had flaky skin, which 
was particularly prominent on the dorsolateral surface of 
the back. Finally, the tip of each transgenic mouse tail be- 
came blackened, followed by a progressive amputation of 
the tail as the animal aged. Adult animals had a mere stub 
for a tail. 
To verify that  the  aberrant phenotype correlated with 
transgene expression, we isolated RNAs from the skins of 
4-d-old  F1  mice,  and  subjected  them  to  Northern  blot 
analysis  with  radiolabeled  human  Dsg3  (test)  and  actin 
(control) cDNAs (Fig. 2 A). Using the human Dsg3 probe, 
we  detected  a  hybridizing  band  in  RNAs  from trans- 
genic animals but not from control mice. The size of the 
major band (1.8 kb) corresponded to the expected size of 
transgene RNA. 
To test for production of intact Dsg3AN, we extracted 
skin proteins and resolved them by electrophoresis through 
9%  SDS polyacrylamide gels. As judged by immunoblot 
analysis, samples from aberrant F1 mice contained a single 
65-kD  Dsg3AN  band  displaying  antigenic  crossreactivity 
with anti-FLAG antiserum (Fig. 2 B). This was within the 
range predicted for Dsg3AN, given the potential for glyco- 
sylation on the remaining extracellular portion of the mu- 
tant protein. Immunoblot analysis was also conducted with 
an anti-bovine desmoglein antibody, DG3.10, whose epitope 
has  been  mapped to  the  cytoplasmic repeating  unit  do- 
mains, present 5, 6, and 2  x  in Dsgl, Dsg2, and Dsg3, re- 
spectively, i.e., the three epidermal desmogleins (Schmelz 
et al.,  1986;  Koch et al.,  1990;  Schafer et  al.,  1994).  The 
strong 130-kD band present in  all samples corresponded 
to the endogenous desmogleins, which are heavily glycosyl- 
ated  and  therefore much larger  than  their  predicted  se- 
quences  (Schmidt et al.,  1994).  Upon longer exposure,  a 
significantly fainter 65-kD band was seen only in protein 
preparations from affected and not unaffected mice (not 
shown).  This  band  corresponded  to  the  migration  of 
Dsg3AN, and was judged to be less than 20 ×  the intensity 
of the 130-kD band. Since the antigenic repeats only share 
50-80%  sequence  identity  across  human  isotypes,  and 
since none of the mouse desmogleins have thus far been 
characterized,  it was not possible for us to use this  anti- 
body to compare the levels of human Dsg3AN with endog- 
enous mouse desmogleins.  This said,  no  transgene  band 
was detected in Coomassie blue-stained SDS-PAGE gels, 
providing further evidence that the expression level of the 
transgene product was low. 
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mice. (A) Northern blot analysis. RNAs were extracted from the 
backskins of 4-d-old transgenic and control animals as described 
previously (Vassar et al., 1989),  except for the use of Trizol re- 
agent (Gibco BRL, Gaithersburg, MD). RNAs (15 Ixg each) were 
then resolved by electrophoresis through formaldehyde agarose 
gels and transferred to nitrocellulose paper. Blots were hybrid- 
ized with radiolabeled eRNA probes against (a) nucleotide resi- 
dues  1-364 of Dsg3AN cDNA, to test for transgene expression 
(shown) and (b) mouse actin cRNA to control for the level and 
integrity of the RNAs (not shown). RNAs are from: lane 1, F1 
mouse of transgenic line 1; lane 2, control littermate of transgenic 
line 1.  Migration of 18S and 28S  rRNAs are indicated at  left, 
along with size standards (in kb). Size of transgenic RNA was 1.8 
kb, and migrated as predicted. (B) Immunoblot analyses. Back- 
skin epidermis from 4-d-old animals was quick frozen, pulverized, 
and resuspended in 8 M urea, 10% r3-mercaptoethanol, and phe- 
nyl methyl sulfonyl fluoride. After brief sonication, residual in- 
soluble material was removed by centrifugation. Total skin ex- 
tracts were  then resolved by electrophoresis through 9%  SDS 
polyacrylamide gels, which were then transferred to nitrocellu- 
lose. paper by electroblotting. The blot was prestained with Pon- 
ceau red to assess that the Ioadings were equivalent (not shown), 
and  then  sequentially  probed,  stripped,  and  reprobed  with 
aFLAG antibody (top), ctDsg antibody (middle), and etK14 anti- 
body (bottom), and developed using the chemiluminescence sys- 
tem  (ECL;  Amersham  Corp.).  For all blots, skin samples are 
from the following F1 mice: lane 1, transgenic from line 2; lane 2, 
control littermate from line 2; lane 3, transgenic from line 1; lane 
4, control littermate from line 1. Molecular mass standards are in- 
dicated in kD at right. As expected, the Dsg3AN transgene prod- 
uct migrated as a single protein of 65 kD, analogous to that also 
seen in Dsg3AN-transfected COS cell extracts (not shown). Note: 
all desmogleins, comigrating at ~130 kD, cross-react with the pan 
anti-desmoglein mouse  monoclonal antibody, DG  3.10,  raised 
against bovine muzzle desmogleins (American Research Prod- 
ucts, Belmont, MA). At long exposure (not shown), the trans- 
gene product could be detected with this antisera. 
Dsg3ddV Expression in the Epidermis Occurs in a 
Pattern Similar to that of  Endogenous Dsg3, and Elicits 
Marked Changes in Intercellular Spaces within the 
Basal and Lower Spinous Layers 
To examine the localization of Dsg3AN in the epidermis of 
trangenic animals, we used immunohistochemistry with an 
anti-FLAG  antibody  (Fig.  3).  Dsg3AN  protein  was  de- 
tected in the basal and lower spinous layers of the epider- 
Figure 3.  Expression of the transgene correlates with an increase 
in intercellular spaces in epidermis of Dsg3AN-expressing trans- 
genic mice. (A-D) Paw skins from 4-d-old F1 transgenic and con- 
trol  animals  of  line  1  were  frozen  on  dry  ice  for  immuno- 
fluorescence. Tissues were sectioned using a Cryostat (8 ~m), and 
processed for indirect immunofluorescence using anti-FLAG and 
anti-desmoglein antibodies.  Immunofluorescence  of transgenic 
(A and B) and control (C and D) skins stained with anti-FLAG 
(aFG; A and C) and anti-desmoglein (aDsg; B and D). Note that 
ctFLAG staining is restricted to transgenic skin, where there is 
weak staining in basal layer, strong staining in lower suprabasal 
layers and weak or absent staining in stratum corneum. Note that 
etDsg staining extended more suprabasally than aFLAG. (E and 
F) Paw skins from 2-d-old animals were fixed and processed for 
semithin sectioning (0.75 ~m) and staining with methylene blue. 
Semithin paw sections are from (E) transgenic line 1 and (F) control 
littermate. Note the increase in intercellular spaces in transgenic 
versus control epidermis. Note also the matted, thickened stratum 
corneum, discussed later, de, dermis; BL, basal layer; SP, spinous 
layers; GR, granular layers; SC, stratum corneum. Bar, 40 ~m. 
mis  of  transgenic  mouse  paw  (A).  The  cells  displaying 
FLAG  immunofluorescence  were  a  subset  of those  that 
showed  staining  with  an  anti-desmoglein  pan  antibody 
(B). The selective presence of anti-desmoglein staining in 
the  uppermost  suprabasal layers was  consistent with  the 
knowledge that Dsgl is a late marker of epidermal differ- 
entiation. Anti-desmoglein is also known to stain Dsg2 in 
the basal layer of the epidermis (Schmelz et al., 1986), al- 
though the intensity of staining in this layer was not appre- 
ciably  different  betweeen  anti-FLAG  and  anti-desmo- 
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was similar to that seen when antisera from PV patients 
were used  to stain  sections from human  or mouse  skin 
(Karpati et al., 1993; Shimizu et al.,  1995,  and references 
therein). In transgenic backskin, staining appeared weaker 
overall and was more prominent in the basal layer (data 
not shown). 
We  next  assessed  whether  expression of Dsg3AN  re- 
suited in changes  in  the  intercellular separations  within 
transgenic mouse epidermis. Semithin sections of palmar 
skin from the paws  of 2-d-old animals  revealed notable 
separations among basal and lower spinous cells of trans- 
genic but not control skin (Fig. 3, E and F, respectively). A 
number of additional morphological abnormalities were 
seen,  and  these will be discussed  later.  The separations 
within epidermis were most notable in paw and tail skin, 
but  were  also  apparent  in  backskin.  These  separations 
were only visible in neonatal skin; within 10 d after birth, 
this difference could no longer be detected. 
Aberrations in the Localization of Some Desmosomal 
Proteins in Epidermal Cells Expressing Dsg3  AN 
As  judged  by immunofluorescence, the  anti-desmoglein 
staining of basal and lower spinous cells seemed somewhat 
more diffuse in some areas of transgenic epidermis than in 
control epidermis (Fig. 3, compare B and D). Even though 
in most cases, the staining was still predominantly periph- 
eral, in some cases, labeling appeared to extend into the 
cytoplasm. This diffuse anti-desmoglein staining was not 
present  in  the  upper  layers  of  transgenic  skin,  where 
Dsg3AN  was  not  present  (B).  Thus,  to  some  extent, it 
seemed to correlate with expression of Dsg3AN. However, 
we show later that the regions such as paw skin, where we 
saw considerable diffuseness, correlated with regions that 
often were hyperproliferative, and therefore likely to be 
undergoing changes in desmosome assembly. When taken 
together with the dependency of the diffuseness on trans- 
gene expression, these data suggested the possibility that 
desmosome assembly may be somewhat altered in trans- 
genic epidermal cells. 
The distribution of other desmosomal products was also 
altered in some areas of Dsg3AN-expressing cells (Fig. 4). 
Thus, for example, antibodies against plakoglobin showed 
some cytoplasmic as well as peripheral labeling in Dsg3AN- 
expressing cells (A-C).  Occasionally, cytoplasmic aggre- 
gates were seen which stained with anti-plakoglobin anti- 
body (arrows, B and D), and also with anti-desmoglein and 
anti-FLAG (arrow, A). Again, in the upper layers where 
Dsg3AN  was  not present,  anti-plakoglobin  labeling  was 
strictly peripheral (Tx red negative in C). The pattern of 
anti-desmocollin staining was also similar to that of anti- 
Dsg3AN and anti-plakoglobin (I, control; J  and K, trans- 
genic), although anti-desmocollin did not colocalize in cy- 
toplasmic aggregates.  As  for anti-plakoglobin, except in 
epidermal regions which we later showed were often hy- 
perproliferative, the labeling was  predominantly periph- 
eral, rather than cytoplasmic. 
In contrast to the somewhat altered staining of anti-pla- 
koglobin and anti-desmocollin, anti-desmoplakin staining 
appeared unchanged,  and remained localized at the cell 
borders in all regions of the epidermis (compare F and G; 
also compare with H). In this regard, it is interesting that 
anti-desmoplakin staining has been detected at the periph- 
ery of some cells that neither possess desmosomes nor ex- 
press desmogleins (Schmelz et al., 1994), and it is known 
that the membrane assembly pathways are distinct for des- 
moplakin and desmogleins (Pasdar and Nelson, 1988; Pas- 
dar et al., 1991). Further experiments will be necessary to 
examine the extent to which our findings are relevant to 
these observations. 
We were intrigued to find that even though anti-E-cad- 
herin staining was still predominantly at the cell periphery, 
it too, was more diffuse in some of the Dsg3AN-expressing 
cells than in control cells (L and M). In the paw skin, it oc- 
casionally colocalized with the transgene product in cyto- 
plasmic aggregates. This was  somewhat surprising, since 
the desmoglein tail segment is known to have sequences 
that exclusively localize to desmosomes and not to classi- 
cal adherens junctions (Troyanovsky et al.,  1994). How- 
ever, E-cadherin perturbations could be elicited indirectly 
by aberrations in plakoglobin distribution, since plakoglo- 
bin is known to bind to the classical cadherins (Sacco et al., 
1995, and references therein). These data suggest that the 
two types of intercellular junctions may be linked, either 
physically through their cytoskeletons, or indirectly, through 
plakoglobin.  Additional evidence related to this issue is 
provided below. 
Structural Defects in the Desmosomes 
of Dsg3  AN-expressing Epidermis 
When taken together, the intercellular separations and ab- 
errations in anti-desmosomal antibody staining suggested 
that  desmosomes  might  be  perturbed  in  cells  that  ex- 
pressed the Dsg3AN transgene. We examined this possibil- 
ity more closely at the electron microscopy level (Fig. 5). 
By ultrastructural analysis, it was readily apparent that in 
many  regions  of 2-5-d-old  transgenic  skin,  the  desmo- 
somes of basal and lower spinous cells were markedly re- 
duced (A; compare with control in B). In many of these ar- 
eas, the numbers of cell projections, i.e., what appear to be 
sites  of  classical  cadherin-mediated  adherens  junctions 
(see below), were also reduced, leaving large intercellular 
gaps (asterisks, A). Despite the loss of most desmosomal 
structures, the few remaining cell projections and/or des- 
mosomes  were  often sufficient to  maintain  intercellular 
adhesion, and only a few cells were left completely without 
connections. Moreover, basal cells remained firmly adher- 
ent  to  the  basement  membrane,  and  hemidesmosomes 
were  of normal  number  and  morphology.  Thus,  while 
Dsg3AN expression led to a marked reduction in classical 
desmosomes, it did not completely disrupt intercellular ad- 
hesions in our mice, nor did its effects extend to the et6134 
integrin-mediated  cell  substratum  adherens  junctions. 
While the extent of desmosomal perturbations varied with 
body region, these overall differences were seen in all skin 
regions. 
Interestingly, there were a number of peculiar intercel- 
lular junctions in the  lower spinous  layers of transgenic 
epidermis  (C).  Some  epidermal  processes  appeared  as 
long zones of adhesion (arrows), but without the plaque- 
like  core  of desmosomes.  The  long  adhesive  processes 
were not observed in control epidermis, but were quite 
Allen et al. Mutant Desmosomal  Cadherin in Transgenic Mice  1371 Figure 4.  Aberrations in desmosomes in epidermal cells expressing Dsg3AN. Paw skin from 4-d-old transgenic and control animals was 
frozen on dry ice, and sections (8 ixm) were subjected to indirect double immunofluorescence as described in Materials and Methods. 
(A-D) Transgenic skin costained with aFG (Tx red in A) and anti-plakoglobin (aPG; FITC in B). Yellow in C shows regions of colocal- 
ization.  (D) Transgenic paw skin stained with aPG showing punctate cytoplasmic staining in some cells. These cells colabeled with aFG 
(not shown). (E) Control skin stained with aPG. (F and G) Transgenic skin costained with anti-desmoplakin (aDP; FITC in G) and 
ctFG (Tx red in F). (H) Control skin stained with ctDP. (/) Control skin  stained with  anti-desmocollin (c~DC; FITC in/).  (J and K) 
Transgenic skin stained with aDC (FITC in J) and aFG (Tx red, shown only is double label in K). (L and M) Transgenic (L) and control 
(M) skin stained with anti-E-cadherin (c~CAD). Notes: both the transgene product and the desmosomal components displayed more 
diffuse and often cytoplasmic staining in the basal and spinous layers of regions of transgenic skin, which were later shown to be under- 
going significant  hyperproliferation; cytoplasmic labeling was markedly reduced in transgenic skin regions of less proliferation, and in 
these areas, labeling was more similar to that of control skin. Bar, 40 txm. 
plentiful in transgenic epidermis.  Some of these adhesion 
zones  were  associated  with  keratin  filaments,  suggesting 
that  they  contained  desmosomal  components,  despite 
their  atypical  structure.  These  abnormalities  will  be  dis- 
cussed in greater depth below. 
Some  desmosomes  were  indistinguishable  from  wild- 
type.  Most of these  normal looking desmosomes were  in 
the upper layers, where Dsg3AN did not appear to be ex- 
pressed  (Fig.  5,  D,  transgenic;  and  E,  control).  Intrigu- 
ingly,  some  transgenic  epidermal  cells  in  the  basal  and 
spinous layers displayed atypical clumps or aggregates of 
keratin  filaments  in  their  cytoplasm  (F).  These  filament 
aggregates  were  not  in  control skin.  These  findings  sug- 
gested that the perturbations  in desmosomes affected the 
architecture of the keratin filament network. 
Given the paucity of desmosomes and their aberrant ap- 
pearance,  we anticipated  that the organization of desmo- 
somal  components  might  be  perturbed  in  the  Dsg3AN- 
expressing cells. To examine this possibility, we conducted 
immunoelectron  microscopy,  using  antibodies  against  a 
number  of the  desmosomal  proteins  (Fig.  6).  In  control 
cells,  anti-desmocollin  labeled  the  membrane  plaque  (A 
and B).  In transgenic  cells,  anti-desmocollin  labeling was 
often organized on only one side  of an intercellular  con- 
nection (arrows,  C; see also inset to C). In addition,  anti- 
desmocollin labeling was also seen over bundles of keratin 
filaments  adjacent  to an  intercellular  connection (arrow- 
heads in  C  denote  the  connection).  These  data  indicated 
that  even  though  much  of the  anti-desmocollin  labeling 
was membrane  associated  (except possibly for regions of 
epidermal hyperproliferation as in Fig. 4), the intercellular 
structures that it labeled were clearly aberrant. 
Results with anti-plakoglobin were similar to those seen 
with anti-desmocollin. However, anti-plakoglobin labeling 
of normal desmosomes was typically arranged in rows par- 
allel to a  membrane plaque  (Fig. 6 D).  In mutant epider- 
mis, plakoglobin was often associated with the membrane 
periphery,  but  in  a  disorganized  fashion  relative  to  con- 
The Journal of Cell Biology, Volume  133, 1996  1372 Figure 5.  Aberrations in the desmosomes of basal and suprabasal epidermal keratinocytes from Dsg3AN-expressing  transgenic mouse 
skin. Paw and buckskins from 2-5-d-old transgenic mouse line 1 and a control littermate were fixed and sectioned for regular electron 
microscopy (see Materials and Methods). (A) Low magnification  of transgenic back skin, revealing normal adherence of basal epider- 
mal cells to the basal lamina, but gross interepidermal separations of basal and lower spinous cells. (B) Control skin at ×2.85 the magni- 
fication as in A. Note the increase in thickness of skin in transgenic relative to control. (C) Higher magnification  revealing peculiar inter- 
cellular junctions in transgenic epidermis. Some junctions appeared as long regions of adhesion, but with no plaque-like structure 
(arrows at top); others resembled desmosomes, but sometimes lacked keratin filaments on one side of the structure (arrows at bottom). 
(D and E) Seemingly normal desmosomes in upper layers of transgenic skin (D) and throughout control skin (E; shown is cell in lower 
layers).  (F) Atypical clumps or aggregates  of keratin filaments in a suprabasal cell of transgenic mouse skin. These aggregates  were 
never seen in control skin and were relatively rare in transgenic skin. They were found in regions where there was a marked paucity of 
desmosomes. KG, keratohyalin granule; LD, lamina densa; Nu, nucleus; mi, mitochondria; KF, keratin filaments; De, desmosome; *, in- 
tercellular space. Bar in (A), 1.8 txm in A; 630 nm in B; 400 nm in C; 200 nm in D; 110 nm in E; and 520 nm in F. 
Allen  et al. Mutant Desrnosomal Cadherin in Transgenic Mice  1373 Figure 6.  Aberrations in the ultrastructure of intercellular adhesion sites containing  Dsg3AN and other desmosomal components. Paw 
skins from 2-d-old transgenic and control mice were fixed and processed for immunoelectron  microscopy as described in Materials and 
Methods. Ultrathin sections of tissues were labeled with ct-PG, ctDSC, c~DP, and aFLAG. The antibody used for labeling  is indicated in 
the lower right of each frame, along with the source of the epidermal tissue (wild-type,  WT, or DSGAN (Mut). (A) Classical desmo- 
somes connecting two basal epidermal cells. (B) Higher magnification of normal desmosome depicting classical plaque-like ultrastruc- 
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both sides of intercellular junctions that possessed keratin 
filament bundles (arrows in upper part of E). However, as 
was seen for anti-desmocollin labeling, these  anti-plako- 
globin-labeled intercellular junctions were devoid of the 
ultrastructure typical of normal desmosomal cores. 
Desmoplakin  also  labeled  peculiar  intercellular  junc- 
tions in the transgenic basal and inner  suprabasal layers 
(F).  Often,  desmoplakin  labeling  concentrated  over the 
keratin filament bundles adjacent to the junction (example 
shown in F). This type of labeling was also seen for plako- 
globin (lower arrowhead in E) and for desmocollin (label- 
ing below arrowheads in C).  Intriguingly, even when the 
transgenic cell labeling with these  antisera was cytoplas- 
mic, keratin filaments were often the sights of these gold 
particles (not shown). Collectively, these data underscore 
the tight association of desmosomal components with the 
keratin filament network. 
A  key question is whether the mutant desmoglein per- 
turbed  desmosomal ultrastructure  by titrating  out  a  key 
component, or whether it did so by physically integrating 
into the structure  and disrupting its architecture. To fur- 
ther explore this issue, we repeated our immunoelectron 
microscopy studies this time using anti-FLAG antibodies. 
Fig. 6 G shows examples of clear labeling of aberrant des- 
mosome-like structures. In this region anti-FLAG showed 
an increased level of cytoplasmic labeling relative to the 
other antibodies, suggesting that not all of the mutant pro- 
tein was targeted to the membrane and incorporated into 
desmosomes. However, the  amount  that  made  it  to  the 
desmosomes  appeared  to  be  sufficient  to  perturb  their 
structure. Whether the cytoplasmic FLAG labeling repre- 
sented a fraction of the mutant protein in a conformation 
that was unable to assemble into desmosomes could not be 
assessed given the experiments described here. 
While very few bona fide desmosomes could be identi- 
fied in the Dsg3AN-expressing cells, those that did appear 
desmosome-like were  often  markedly shorter  than  nor- 
mal. While electron microscopy of ultrathin sections could 
not be used to measure absolute lengths of desmosomes, 
the average length of transgenic desmosomes was signifi- 
cantly shorter than that of control desmosomes. Atypically 
short desmosomes were also seen in the upper suprabasal 
layers, although in these layers, longer desmosomes were 
also seen (Fig. 6 H). Wherever typical desmosomal mor- 
phology was observed, desmosomes displayed typical la- 
beling with anti-plakoglobin (H). 
Finally, we examined the cell-cell adherens junctions by 
using  anti-E-cadherin  and  anti-plakoglobin  antibodies. 
Control  cells  displayed  numerous  and  highly  organized 
cell projections, which labeled heavily with the antibody 
(Fig. 7 A). While these projections did not resemble inter- 
cellular adherens junctions in simple epithelia, they were 
sites  of  epidermal  cell--cell  contact,  and  they  labeled 
strongly  and  highly  specifically  with  antibodies  against 
E-cadherin and plakoglobin. The only other anti-E-cadherin 
labeling  seen above background  in  these  tissue  sections 
was located at the cell membrane at sites of noncell con- 
tact and at levels appreciably lower than that observed at 
projection sites. These projections are numerous and rich 
sources  of intercellular  contact  in  the  epidermis.  Thus, 
while anti-catenin labeling will be necessary to unequivo- 
cally resolve this point, it seems likely that these are bona 
fide E-cadherin-mediated adherens junctions. 
In  contrast  to  the  control  tissue,  these  projections  in 
Dsg3AN-expressing cells seemed more disorganized  and 
aberrant (Fig. 7, arrowhead, B). Often projections from a 
single cell associated (arrow, B). While some intercellular 
projections appeared unperturbed  (thick arrows, C), the 
overall numbers  of normally looking junctions  were  re- 
duced relative to control tissue and seemed to be replaced 
by  the  peculiar  junctions  (arrows,  C).  These  data  sug- 
gested that the classical adherens junctions were altered in 
transgenic epidermal cells.  Evidence  consistent with  this 
notion came from anti-plakoglobin labeling of these junc- 
tions in the mutant cells (D and E). In some cases, sites of 
intercellular  contact showed little or no labeling  (D).  In 
other cases, only one-half of a projection site of intercellu- 
lar  contact  labeled  with  the  antibodies  (E).  These  half- 
labeled junctions were reminiscent of the half-labeled des- 
mosomal junctions  that  we  observed  in  the  transgenic 
cells. 
Expression of Dsg3 AN Elicits Dramatic Morphological 
Changes in Epidermal Differentiation 
At the light microscopy level, striking morphological ab- 
normalities could be seen in the architecture and differen- 
tiation  of transgenic  epidermis.  Aberrations  were  in  all 
skin regions of neonatal animals, although the morphology 
varied significantly throughout  the transgenic epidermis. 
The example shown in Fig. 8 A is an especially affected re- 
gion of the skin of the top (not palmar) side of the paw. In 
this  and  comparable areas,  the  epidermis was  markedly 
and  variably thickened  (compare  with  B,  control).  The 
epidermis contained two to three times greater numbers of 
spinous layers, and the cells within these layers were disor- 
ganized.  Often,  the  stratum corneum was thickened  and 
matted (A). The granular layer was of variable thickness, 
sometimes reduced  (Fig.  8 A)  and  sometimes increased 
(Fig. 3 E). Some regions of transgenic backskin displayed 
similar abnormalities (Fig. 8 C). Occasional eosinophilic cells, 
ture, labeling with aDSC. (C) Transgenic basal cell showing disorganized labeling of aberrant desmosomes. Note presence of some des- 
mosomes that show aDSC labeling  on only one side of a junction (arrows in C; inset, C). Note also presence of bundle of keratin 
filaments, labeled with aDSC and located only on bottom side of a junction (arrowheads). (D) Two normal desmosomes interconnect- 
ing two lower spinous cells. Note that c~PG labeling is more concentrated next to, rather than directly on, these plaques. (E) Transgenic 
intercellular  connections  between two lower spinous cells. Note aPG labeling at these junctions  (arrow), despite the lack of a typical 
plaque-like structure.  (F) aDP labeling of an aberrant intercellular  junction  (arrowheads), with cluster of keratin filaments that show 
marked labeling with aDP. (G) Aberrant desmosome-like structures of transgenic skin. Note labeling with oLFLAG (arrows), indicating 
that the transgene product localizes to these structures.  (H) Desmosomes in the granular layer of transgenic skin. kf, keratin filaments; 
De, desmosome; *, intercellular  spaces; KG, keratohyalin granule. Bar in (A), 200 nm in A, inset to C, and G; 80 nm in B; 160 nm in C 
and D; 130 nm in E; 250 nm in Fand 180 nm in H. 
Allen et al. Mutant  Desmosomal  Cadherin in Transgenic  Mice  1375 Figure 7.  Aberrations in the ultrastructure of intercellular adhesion sites containing E-cadherin and plakoglobin. Paw skins from 2-d-old 
transgenic and control mice were fixed and processed for immunoelectron microscopy as described in Materials and Methods. Ultrathin 
sections of tissues were labeled with anti-E-cadherin (aCAD) and anti-plakoglobin (aPG). The antibody used for labeling is indicated 
in the lower right of each frame, along with the source of the epidermal tissue (wild-type, WT or DSGAN, Mut). (A-C) aCAD labeling 
of cell-cell adherens junctions in lower spinous layers. Note the differences in regularity and uniformity of the cell projections between 
control and transgenic cells. Note also the wide intercellular gaps (asterisks) between transgenic cells. Note also the labeling along the 
membrane, in addition to cell to cell junctions. Note that many of the junctions are aberrant (arrow, C), while others are seemingly nor- 
mal (open arrowheads). (D and E) etPG labeling of lower spinous layer adherens junctions. Note labeling of only one half of the junction 
in E, and absence of labeling in junctions in D. De, desmosome; kf, keratin filaments; Nu, nucleus; *, intercellular spaces. Bar in (A), 220 
nm in A; 360 nm in B; 430 nm in C; 180 nm in D; and 110 nm in E. 
signs of premature  keratinocyte degeneration, were seen 
in the upper layers near the stratum corneum (arrow, C). 
In palmar regions of paw skin, where nonbullous edema 
was detected, the epidermis sometimes showed pustules in 
the stratum corneum (D). These pustules contained infil- 
trates composed of neutrophils. The dermis underlying the 
affected epidermis contained both neutrophils and mono- 
nuclear cells, and was extremely watery, as judged by ex- 
pansive loose and clear spaces. These were signs of an acute 
inflammatory  response.  Intriguingly,  the  edema  and  in- 
The Journal of Cell Biology, Volume 133, 1996  1376 Figure 8.  Alterations in tissue morphology in skin of Dsg3AN-expressing transgenic mice. Paw, back, and tail skins from 5-d-old F1 ani- 
mals of transgenic lines  1 and 2 and their control littermates were placed in Bouin's fixative  for histology. Fixed tissues  from 5-d-old 
mice were embedded in paraffin and sectioned (5 p~m). Sections were stained with hematoxylin and eosin.  (A and B) Sections of trans- 
genic and control paw skin, respectively. (C) Section of transgenic back skin, showing eosinophilic cell (arrow) in upper layer. Note: con- 
trol paw skin (shown in B) is slightly thicker than control backskin (not shown). (D) Section of transgenic paw skin showing pustule and 
immune infiltrate in upper epidermal layers.  (E and F) Low magnification of tail tips from transgenic and control skins, respectively. 
Note signs of degeneration, with aggregates of blood cells in transgenic tail tip. In this region, the epidermis was completely missing (G 
and H). Higher magnification of regions of tail skin slightly removed from the blackened epidermis. Note the presence of a matted stra- 
tum corneum and presence of nuclei (arrows) in the stratum corneum of G. This is referred to as parakeratosis. Note also the degenera- 
tive basal ceils within the epidermis (arrows, H). (I) Control tail skin epidermis, revealing a single layer of healthy basal cells, an orga- 
nized spinous, granular and stratum corneum layers, and regularly spaced hair follicles. Bar in (A), 30 Ixm in A, B, C, H, and I; 50 ~m in 
D and G; 100 p~m in E and F. 
flammation  appeared  in  the  paws  of transgenic  mice  at 
~1-2 d after birth, and remained prominent until d 4-7 af- 
ter birth, i.e., a time at which transgene expression was be- 
ing reduced,  as  surface  hairs  increased  in  numbers.  The 
consistency  of the  behavior  and  timing  of the  response 
made it unlikely that it was due to bacterial infection. In 
agreement  with  this  notion  was  the  absence  of staining 
with reagents specific for gram positive and gram negative 
bacteria. 
Additional  abnormalities  were  prominent  in  the  tail, 
where progressive self-amputation was a hallmark of these 
mice.  Histologic  examination  of  the  tail  tip  revealed  a 
complete lack of epidermis and signs of severe vascular le- 
sions and degeneration (Fig. 8 E; compare with control in 
F). Further away from the tip, discernable epidermis could 
be identified (G and H). In these regions, abnormalities in 
the upper  differentiating  layers were striking.  Often,  nu- 
clei were prevalent in the stratum corneum, a feature com- 
monly referred  to  as  parakeratosis  (arrows,  G).  In addi- 
tion, the statum corneum was often thicker than the rest of 
the epidermis. Cells in the basal layer and first few spinous 
layers showed severe signs of degeneration, with pyknotic, 
condensed nuclei  surrounded  by clear cytoplasm (H, ar- 
rows;  compare  with  control  in/).  Often  separations  be- 
tween  epidermal  cells  appeared  even  greater  than  those 
shown  in  Fig.  3.  Even  in  regions  that  were  centimeters 
away from the  tail  tip,  eosinophilic,  degenerating  kerati- 
nocytes and cell disorganization were prevalent (not shown). 
Whether these degenerative signs were reflective of necro- 
sis or apoptosis remains to be explored. 
In summary, throughout the epidermis of Dsg3AN mice, 
marked changes in the overall morphology occurred, and 
these changes extended to upper differentiating layers, de- 
spite  the lack of Dsg3AN in these  layers.  We do not yet 
fully  understand  the  variability  either  between  different 
body sites or within regions of a particular body site; how- 
ever, there  did seem to be  a  correlation between  the de- 
gree of desmosomal perturbations  and the severity in ab- 
errant differentiation. While variations in mechanical stress 
are likely to exacerbate regional differences, it may also be 
that there are as yet unexplored regional variations in pat- 
terns of desmoglein gene expression. 
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Epidermal Proliferation 
The hyperthickened epidermis of the back and pawskin of 
Dsg3AN  mice  suggested  that  keratinocyte  proliferation 
had been upregulated. To examine this possibility, we sub- 
jected  6-d-old  animals  to  intravenous  injections  of bro- 
modeoxyuridine (BrdU).  2  h  later,  backskins were fixed 
and  processed  for  immunohistochemistry  with  an  anti- 
BrdU  antibody.  In  some  regions  of  the  epidermis,  a 
marked increase was seen in the number of labeled cells. 
In  regions  where  morphological  differences  were  most 
prominent, the number of labeled cells was up to 5-8  x 
that of control samples (representative examples shown in 
Fig. 9 A, transgenic; and B, control). In control skin, all la- 
beled keratinocytes were located as expected, i.e., in the 
basal epidermal layer (arrow in B),  or in  the  outer root 
sheath  or matrix of hair follicles. However in  transgenic 
epidermis, some labeled cells were also in the first supra- 
basal layer (A, arrow),  a feature typical of hyperprolifera- 
tive skin disorders (for review see Potten, 1981). 
The aberrations in morphology and hyperproliferation 
suggested that terminal differentiation might be biochemi- 
cally  altered  in  the  hyperthickened  areas  of  Dsg3AN- 
expressing epidermis. To examine this possibility, we used 
immunohistochemistry with antibodies against a variety of 
differentiation markers known to be perturbed  in hyper- 
proliferative skin disorders (Stoler et al., 1988).  Most nota- 
bly, antibodies  against K14 revealed stronger staining in 
many suprabasal than basal cells (Fig. 9 C; compare with 
control in D). This biochemical change, also seen in psori- 
asis and other proliferative disorders, is known to be regu- 
lated at the mRNA level (Stoler et al.,  1988),  and hence 
may have contributed  to the suprabasal Dsg3AN expres- 
sion seen in our mice. 
We also detected spinous layer expression of K6 (E and 
F) and [31 integrin (not shown), features typical for hyper- 
proliferative  disorders  (Sun  et  al.,  1984;  Carroll  et  al., 
1995).  Moreover, the extension of anti-[31  antibody label- 
ing into the suprabasal layers of transgenic epidermis indi- 
cated that expression of integrins could be influenced by 
alterations  in  cell  adhesion,  consistent  with  previous  in 
vitro  studies  (Hodivala  and  Watt,  1994).  Given  recent 
findings by Carroll et al. (1995), the observation presented 
a  possible  mechanism  for  the  hyperproliferation  in  our 
transgenic mice. Finally, in addition to changes in spinous 
layers, a  decrease was observed in  anti-filaggrin labeling 
(G; compare with control in H) and in loricrin labeling (I; 
compare  with  control  in J).  These  changes  were  in  the 
granular  layer, where  transgene  expression  was  not  ob- 
served. However, they are both changes often  accompa- 
nied by hyperproliferation. 
The induction of hyperproliferative markers occurred in 
Figure 9.  Hyperproliferation and altered biochemistry in the epi- 
dermis of DsgAN transgenic  mice. Five-d-old transgenic  (MUT) 
and normal mice were injected with 100 t~g BrdU in 0.8% NaCI, 1 
mM Tris.HC1, pH 8.0, 0.25 mM EDTA, per gram of body weight. 
After 2 h, mice were killed and back and tail skins were placed in 
Bouin's fixative,  embedded in paraffin,  and sectioned  (5  I~m). 
First section of every set is transgenic; second section is control. 
Shown are representative sections subjected  to immunogold la- 
beling  with  antibodies  against  the following: (A  and B) BrdU. 
Arrow in A  denotes labeled  suprabasal  cell, frequently seen in 
transgenic skin, and never seen in control skin. (C and D) COOH- 
terminal peptide of mouse/human K14; (E and F) COOH-terminal 
peptide of mouse K6; arrow in F is to inner layers of outer root 
sheath,  positive  for K6.  (G and H) mouse filaggrin;  (I and J) 
COOH-terminal peptide to mouse loricrin. HF, hair follicle. Bar, 
20 I~m. 
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However, in some body regions, e.g., the tail, degeneration 
was more prominent than proliferation, and BrdU labeling 
was nearly absent (not shown). A  possible explanation for 
these  observations is that in regions where perturbations 
in  cell  adhesion  are  prevalent,  hyperproliferation  is  in- 
duced,  whereas in regions where gross disruption  in  cell 
adhesion takes place, cell death ensues. While further ex- 
periments will be necessary to assess the extent to which 
this hypothesis is correct, our findings to date are in sup- 
port of this idea. 
Are There Phenotypes that Go Beyond Mere 
Desmosomal Disruption? 
Several phenotypes in Dsg3AN-expressing mice were not 
only unexpected, but at present remain unexplained  at a 
molecular level. Most notable was the overall appearance 
of adult mice (Fig. 10 A). Both males and females were no- 
ticeably smaller than their normal littermates. One trans- 
genic line of F1 mice averaged 35--45% the normal weight, 
and the other line averaged 50-60% of the normal weight 
of their control littermates. Dissection revealed a marked 
reduction  in fat pads of transgenic mice. The lack of fat 
was also evident in the skin, where the dermis was conse- 
quently markedly thinner than normal (B). In contrast to 
neonatal  skin,  the  epidermis  of older  animals  was  only 
slightly  thicker  than  control  skin  (compare  C  with  D). 
Electron microscopy confirmed that a  near normal com- 
plement of desmosomes was  present  in  adult  epidermis 
(not shown). These data are consistent with the reduction 
in K14 promoter activity known to occur with age (Zinkel, 
S.,  and  E.  Fuchs,  unpublished  observations).  They  also 
provide further support for the notion that a threshold level 
of Dsg3AN is necessary to produce desmosomal defects. 
Another notable difference in our older transgenic mice 
was a constantly wet and matted hair coat, a feature partic- 
ularly prominent in male animals (Fig.  10 A).  Curiously, 
these  animals  also  groomed  themselves  constantly,  so 
much so that they were often on two feet rather than four. 
These  mice  also  drooled,  further  contributing  to  a  wet 
coat. It is known that the K14 promoter is active in neona- 
tal  and  adult  salivary glands,  and  that  male  and  female 
glands develop differently in mice (Guo et al., 1993). His- 
tological examination of the salivary glands revealed strik- 
ing differences in both the columnar, intercalated tubular 
cells, which produce mucus saliva, and the alveoli, which 
produce watery saliva (E, transgenic male; compare with 
F, control). There were markedly fewer tubules in the sub- 
mandibular gland of the trangenic mouse. Some of these 
tubules showed signs of atrophy. In those still functional, 
secretions were significantly more prominent than in con- 
trol glands.  Moreover, instead of being granular,  as they 
were in the  control, the secretory material was distinctly 
homogeneous in nature. 
Discussion 
Perturbing Cell Adhesion In Vivo: What Are the 
Molecular Mechanisms Involved? 
Our studies demonstrate unequivocally that expression of 
Figure 10.  Adult Dsg3AN mice display  a bizarre behavior and 
appearance. (A) A  2-mo-old  animal from transgenic  line  1, re- 
vealing wet and matted hair coat, due in part to virtually nonstop 
grooming.  (B-D) Methylene  blue-stained semithin  sections  of 
transgenic (B and C) and control backskins (D). Note thin dermis 
in B due to absence of skin fat. Note that transgenic epidermis of 
older mice is only slightly thicker than that of control, mu, muscle 
(E and F) Hematoxylin and eosin-stained  sections  of transgenic 
(E) and control (F) submandibular male salivary glands. Arrows 
in F denote granular nature of salivary solutions. In contrast,  the 
mutant's salivary solutions were homogeneous. 
a mutant Dsg3 in epidermal cells can perturb desmosome 
assembly and structure in vivo, in a fashion similar to the 
effects of an analogous mutant N-cadherin on classical ad- 
herens junctions. Our data imply that there are two different 
ways in which aberrations in Dsg3 can alter human pathol- 
ogy: one elicited by pathogenic PVA antibodies (Amagai 
et al., 1992)  and the other generated by genetic mutations 
in Dsg3. 
The  expression  level of our transgene  appeared  to be 
low in most epidermal cells, as judged by weak desmoglein 
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desmogleins, and by the absence of a discernable Dsg3AN 
band  in  Coomassie blue-stained  gels.  This  may explain 
why  desmosomes  were  not  completely lost  in  Dsg3AN 
transgenic  mice  as  they  are  in  Pemphigus  Vulgaris  pa- 
tients. This said, the levels of Dsg3AN were sufficient to 
disrupt many of the desmosomes in the basal and lower 
spinous layers of neonatal epidermis. Intriguingly, despite 
the  absence of membrane plaques with classical desmo- 
some ultrastructure, intercellular associations still formed 
that labeled with antibodies against plakoglobin, desmo- 
collin, desmoplakin, and FLAG (transgene product), and 
these structures associated with keratin filaments. Taken 
together with our regular electron microscopy data, it ap- 
pears that even when the desmosome core is  disrupted, 
thereby ablating the typical ultrastructure of the plaque, 
zones of adhesion containing desmosomal components can 
nevertheless still form. These sites of intercellular associa- 
tions frequently seemed to have one-half of a plaque-like 
structure, suggesting that plaque disruption or perturbation 
need not necessarily occur on both sides of each desmosome. 
It is important to consider that [3-catenin and plakoglo- 
bin, homologous proteins which can associate with classi- 
cal cadherins, exist in at least one and possibly more, solu- 
ble forms that have unique, as yet unidentified functions 
(for review see Klymkowsky and Parr, 1995).  We cannot 
unequivocally rule out the possibility that our mutant des- 
moglein acted by influencing the soluble pool of plakoglo- 
bin. However, we only observed an increase in cytoplas- 
mic  plakoglobin  in  areas  of  Dsg3AN-expressing  skin 
where there was extensive hyperproliferation. In these re- 
gions, cytoplasmic plakoglobin appeared to associate with 
Dsg3AN and other desmosomal components, and we spec- 
ulate that this may be a  reflection of an increase in the 
pools of desmoglein-plakoglobin preassembly complexes 
in hyperprolfierating epidermis. When taken together with 
our supposition that the levels of Dsg3AN are likely to be 
low in our transgenic mice, it seems unlikely that our mu- 
tant acted solely by interfering with putative non-adher- 
ence functions for cytoplasmic plakoglobin. 
It was intriguing that in some regions of transgenic skin, 
cell projections were markedly reduced. Immunoelectron 
microscopy confirmed that these structures are involved in 
classical cadherin-mediated adherens junctions in the epi- 
dermis. This finding is likely to be relevant in light of the 
fact that in Pemphigus Vulgaris, complete loss of intercel- 
lular adhesion occurs in basal  and lower spinous layers, 
giving rise to a  "tombstone row" appearance of the cells 
(Lever and Schaumberg-Lever, 1990). Thus, by extrapola- 
tion, it appears that in both PV and in Dsg3AN transgenic 
mice, reduction  in  desmosomes  leads  to  a  reduction  in 
E-cadherin-mediated junctions. In contrast, such a corre- 
lation did not seem to exist in A431 carcinoma cells trans- 
fected  with  a  chimeric  connexin-Dsgl  mutant  (Troy- 
anovsky  et  al.,  1994).  We  cannot  rule  out  that  these 
differences may stem from different mechanisms of des- 
mosome disruption in these systems, but prefer an alterna- 
tive explanation, namely that when there is a reduction or 
alteration in desmosomes in vivo, the classical cadherin- 
mediated junctions are not sufficiently stable on their own 
to withstand the mechanical stresses of the environment. If 
as seems likely, the aberrant desmosomes are also sensi- 
tive to stress, then this feature, coupled with a reduction in 
transgene expression, could account for the overall reduc- 
tion seen in histological defects as the animals developed a 
protective hair coat. 
Relation between Disruption  of Desmosomes and 
Changes in Cell Growth and Differentiation 
An intriguing and important finding of our studies is that 
the  perturbation  in  epidermal  desmosomes  in  neonatal 
mice resulted in a marked increase in proliferation and hy- 
perplasia  within  the  epidermis.  A  number  of  possible 
mechanisms underlie this phenomenon. One could argue 
that this is caused by the concomitant reduction in classical 
cadherin-mediated junctions, a phenomenon that has been 
linked  to hyperproliferation in many systems  (Takeichi, 
1993; Birchmeier and Behrens, 1994; Hermiston and Gor- 
don,  1995).  Alternatively,  the  increase  in  proliferation 
could be attributed to the observed induction of [31 inte- 
grin in the suprabasal layers, a feature associated with pso- 
riasis, and recently shown to elicit epidermal hyperprolif- 
eration in vivo (Carroll et al.,  1995). Also, it is possible 
that perturbation of the epidermal barrier function is the 
basis  for induced proliferation. An  ability of underlying 
cells to sense a defect in the overlying epidermis and re- 
spond by proliferating has been noted in epidermolytic hy- 
perkeratosis, a degenerative disorder involving mutations 
in  suprabasal  keratins  (for  discussion  see  Fuchs  et  al., 
1992).  Loss of barrier function has also been proposed to 
account  for  elevated  proliferation  in  other  disorders 
(Nickoloff and Naidu,  1994). Irrespective of mechanism, 
the fact that a mutant desmoglein can lead to epidermal 
proliferation in vivo has important ramifications regarding 
our understanding  of desmosomal functions. It presents 
the formal possibility that the reductions in desmosomes, 
often associated with patients with squamous cell carcino- 
mas, may be an active rather than passive contributer to 
the enhanced proliferation seen in these tumors. 
Finally,  a  remarkable  and  unexpected  finding  of our 
studies is that the expression of a mutant desmoglein elic- 
ited a myriad of morphological and biochemical changes 
in transgenic mice. Some of these, such as the suprabasal 
induction  of K6  and  [31  integrin,  the  loss  of a  granular 
layer, and  the  increase in  thickening and  parakeratosis, 
could be directly associated with the increase in hyperpro- 
liferation  in  the  epidermis.  However,  other  traits  were 
completely  unpredicted  and  include  disorganization  of 
cells within the epidermis, edema in palmoplantar skin, in- 
flammatory  response,  formation  of epidermal  pustules, 
tail amputation, and defects in salivary glands. 
Our knowledge that the mutant desmoglein leads to a 
reduction in cell adhesion provides explanations for some 
of the  unusual  phenomena we  detected.  It seems  likely 
that  when  cells  have  reduced  adherence, their outward 
movement towards the skin surface cannot proceed in a 
typically orderly fashion. In addition, while epidermal hy- 
perproliferation seemed to be a reaction to a reduction in 
cell adhesion, epidermal cell death appeared to be the re- 
action to massive loss of cell adhesion, as occurred in the 
tail. In this regard, it is well known from in vitro studies 
that cells plated at a density which allows some cell-cell 
contact will proliferate, while those plated at low density 
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Green, 1975; Frisch and Francis, 1994).  Some of the other 
biological  peculiarities  of  our  mice  are  less  readily  ex- 
plained, and remain curious enigmas. As future studies are 
conducted, the molecular pathways involved in these sec- 
ondary responses should become more clear. 
Relations between the Pathophysiologies 
of  Dsg3AN Mice, Pemphigus Vulgaris, and Other 
Human Genetic Disorders 
The loss of cell adhesion in our Dsg3AN mice was not as 
severe as that which exists in Pemphigus Vulgaris patients, 
where  widespread  acantholysis  is  seen  in  the  basal  and 
lower spinous layers (Fitzpatrick et al.,  1993).  In this re- 
gard, it may be relevant that C3 and other components of 
the  complement pathway  are  known  to  be  activated  by 
pemphigus IgG (Fitzpatrick et al., 1993), and this may ex- 
acerbate the loss of cell adhesion  and the  blistering pro- 
cess in PV patients.  In addition, we have discovered that 
despite the  ability to perturb desmosomes, expression of 
our truncated desmoglein at low levels (and most likely a 
milder mutant desmoglein at much higher levels) does not 
obliterate cell adhesion. This finding is crucial in contem- 
plating the types of genetic disorders that may arise from 
mutations in desmosomal components.  Our data provide 
compelling evidence that desmosomes do not have to be 
completely disrupted  in  a  genetic disorder  involving de- 
fects in desmogleins. In fact, our data suggest that in the 
absence of substantial mechanical stress and with milder 
desmoglein mutations,  it may be difficult to detect what 
are likely to be subtle differences in the ultrastructure  of 
the aberrant desmosomes. 
Given  this  finding,  it  is  not  surprising  to  find  that 
Darier's disease and Hailey-Hailey's disease, two genetic 
disorders  typified  by  massive  loss  of epidermal  desmo- 
somes, do not map to chromosome 18q where the genes 
for the desmogleins and desmocollins reside. Conversely, 
in  light  of our  data,  it  is  intriguing  that  a  form of pal- 
moplantar keratoderma (PPK) has recently been mapped 
near the  desmosomal cadherin  gene  cluster  (Hennies  et 
al.,  1995).  The nonepidermolytic forms of this autosomal 
dominant group of diseases are typified by thickening of 
the  palmoplantar  epidermis  and  epidermal  hyperplasia 
(Fitzpatrick et al.,  1993).  Interestingly, one form of non- 
epidermolytic PPK contains a point mutation in keratin 1 
(Kimonis et al., 1994), in a region important for the associ- 
ation between desmoplakin and keratins in vitro (Kouklis 
et al., 1994).  Taken together with our studies showing that 
the paws are the most affected areas of our animals, and 
that the major histopathological and/or ultrastructural fea- 
tures  of the  skin include  flakiness, epidermal thickening 
and hyperplasia, and cytoplasmic aggregations of keratin 
filaments, a defect in a desmoglein could account for much 
of the  pathology seen  in  the  form of PPK  described  by 
Hennies et al. (1995). 
As with any transgenic approach, it has been difficult to 
sort out the relation between the Dsg3AN mouse pheno- 
type and a possible corresponding human genetic disease. 
Neonatal  mouse  and  human  skin  are  quite  similar,  and 
hence we have primarily concentrated on very young ani- 
mals  in  drawing  correlations.  However  unlike  humans, 
mice quickly develop thick hair coats, and by 7-10 d, their 
epidermis has been concomitantly reduced  to just  a  few 
cell layers. Not only does the protective hair coat make it 
difficult to assess mechanical stress effects on the epider- 
mis, but in addition, the thinness of the epidermis makes it 
difficult to assess molecular abnormalities in the spinous 
and  granular  layers.  Moreover,  keeping  our  mice  in  a 
pathogen-free facility precludes  our  ability to determine 
the  effects of epidermal barrier loss on the immune sys- 
tem. When taken together with the use of a  keratin pro- 
moter to drive our transgene, and with a  mutant which is 
likely to be unnaturally severe, we can only speculate as to 
the possible relation of our mice to human disease. Given 
this caveat, we have discounted some defects, e.g., salivary 
gland perturbations and lack of fat, on the basis of differ- 
ences in transgene expression; we have discounted others, 
e.g.,  the  improved  adult  epidermal  phenotype,  on  the 
bases  of transgene  levels  and  hair  coat.  If these  adjust- 
ments are indeed valid, the parallels between such disor- 
ders as PPK and our mice become even greater. 
Certain  features of other  disorders  are  also  consistent 
with the pathophysiology of our mice. Like PPK, nonepi- 
dermolytic variants of some other known keratin disorders 
are  candidates  for desmoglein defects.  Additionally,  the 
pathogenesis of Dsg3AN-expressing tail epidermis resem- 
bled to some extent that of Pityriasis lichenoides chronica 
(PLC), a cutaneous disease of unknown etiology, typified 
by multiple small erythrosquamous ulceronecrotic lesions 
(Fitzpatrick et al., 1993). Also, the pathogenesis of paw and 
backskin epidermis of our mice resembled that of psoriasis 
in some ways. This said, both PLC and psoriasis are typified 
by robust leukocytic infiltrates, something we did not detect 
in our mice. While it is not likely that they are genetic dis- 
orders of desmosomal components, some of their second- 
ary effects may be shared with those of our Dsg3AN mice. 
In closing, our results provide new insights into the clini- 
cal  manifestations  that  can  result  from abnormalities  in 
cell  adhesion.  Our  studies  have  helped  us  to  elucidate 
likely candidates for desmoglein defects, as well as to un- 
derstand  some  of the  pathophysiology of disorders  that 
may  not  necessarily  be  directly  attributable  to  desmo- 
somal defects, but that are associated with abnormalities 
in cell adhesion. 
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